RSS

sepsis

A new therapy could stop the early stages of sepsis from triggering organ damage, research suggests. Read more

News

The European Sepsis Academy (ESA) has initiated the Innovative Training Network (ITN) which offers PhD students a sepsis-oriented joint training programme at institutes and companies in the field Read more

News

Pfizer has acquired a minority equity interest in AM-Pharma, a privately held Dutch biopharma company focused on the development of recAP for inflammatory diseases, and secured an exclusive option to acquire the remaining equity in the company. Read more

News